A new pharmophoric model for 5-HT reuptake-inhibitors: differentiation of amphetamine analogues
- 31 May 1994
- journal article
- Published by Elsevier in Pharmaceutica Acta Helvetiae
- Vol. 68 (4) , 235-244
- https://doi.org/10.1016/0031-6865(94)90054-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Three-dimensional structure-activity relationshipsTrends in Pharmacological Sciences, 1988
- Graphics computer-aided receptor mapping as a predictive tool for drug design: development of potent, selective, and stereospecific ligands for the 5-HT1A receptorJournal of Medicinal Chemistry, 1988
- Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sitesEuropean Journal of Pharmacology, 1988
- Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brainBiochemical Pharmacology, 1987
- Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogsEuropean Journal of Pharmacology, 1987
- Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic classJournal of Medicinal Chemistry, 1986
- The ensemble approach to distance geometry: application to the nicotinic pharmacophoreJournal of Medicinal Chemistry, 1986
- Computer-assisted investigation of structure-activity relationships in serotonin-uptake blockersJournal of Molecular Graphics, 1985
- Effects of certain hallucinogenic amphetamine analogs on the release of [3H]-serotonin from rat brain synaptosomesJournal of Medicinal Chemistry, 1982